Optimizing The Administration Of Tyrosine Kinase Inhibitors With Chemoradiotherapy To Improve Outcomes In Locally Advanced, Egfr Plus Nsclc Using An Evolutionary Tumor Progression Model
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS（2019）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要